| EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target K Toner, CM Bollard Blood, The Journal of the American Society of Hematology 139 (7), 983-994, 2022 | 32 | 2022 |
| The Handy Eye Check: a mobile medical application to test visual acuity in children KN Toner, MJ Lynn, TR Candy, AK Hutchinson Journal of American Association for Pediatric Ophthalmology and Strabismus …, 2014 | 21 | 2014 |
| Novel TCR-like CAR-T cells targeting an HLA∗ 0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia S Raskin, S Van Pelt, K Toner, PB Balakrishnan, H Dave, CM Bollard, ... Molecular Therapy-Methods & Clinical Development 23, 296-306, 2021 | 19 | 2021 |
| Children with medical complexity: a web-based multimedia curriculum assessing pediatric residents across North America NH Shah, P Bhansali, A Barber, K Toner, M Kahn, M MacLean, M Kadden, ... Academic Pediatrics 18 (1), 79-85, 2018 | 19 | 2018 |
| Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma H Dave, M Terpilowski, M Mai, K Toner, M Grant, M Stanojevic, C Lazarski, ... Blood Advances 6 (2), 473-485, 2022 | 16 | 2022 |
| Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults J Rubinstein, K Toner, T Gross, B Wistinghausen Best Practice & Research Clinical Haematology 36 (1), 101446, 2023 | 15 | 2023 |
| T-cell therapies for T-cell lymphoma K Toner, CM Bollard, H Dave Cytotherapy 21 (9), 935-942, 2019 | 12 | 2019 |
| Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study B Wistinghausen, K Toner, DA Barkauskas, LP Jerkins, H Kinoshita, ... Blood advances 8 (5), 1116-1127, 2024 | 5 | 2024 |
| Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures CA Lazarski, K Toner, MD Keller, N Luban, PP Young, CM Bollard, ... Blood Transfusion 19 (6), 456, 2021 | 5 | 2021 |
| Children with medical complexity: a web-based multimedia curriculum assessing pediatric residents across North America. Acad Pediatr. 2018; 18 (1): 79-85 NH Shah, P Bhansali, A Barber | 5 | |
| Applications of cell therapy in the treatment of virus-associated cancers K Toner, CD McCann, CM Bollard Nature Reviews Clinical Oncology 21 (10), 709-724, 2024 | 4 | 2024 |
| CD19 CAR-T cell therapy for Relapsed or Refractory Diffuse Large B Cell Lymphoma; Why does it Fail? H Kinoshita, CM Bollard, K Toner Seminars in Hematology, 2023 | 4 | 2023 |
| Pediatric cutaneous T‐cell neoplasm and mimics with gamma‐delta expression: Not always aggressive J Cheng, K Toner, K Habeshian, M Cardis, EW Cowen, CM Bollard, ... Pediatric blood & cancer 71 (3), e30837, 2024 | 2 | 2024 |
| Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas JD Bender, S Damodharan, CM Capitini, A Moskop, K Toner, A Vatsayan, ... Blood Advances 8 (15), 4164-4168, 2024 | 1 | 2024 |
| Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma K Toner, CE Allen, S Jain, B Kahl, J Leonard, H Wasserstrom, ... EJHaem 4 (4), 921-926, 2023 | 1 | 2023 |
| Tumor associated antigen specific T cells given in combination with nivolumab for the treatment of Hodgkin lymphoma H Dave, M Mai, M Terpilowski, K Toner, M Stanojevic, M Galligan, A Shibli, ... Blood 136, 18, 2020 | 1 | 2020 |
| Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted drug era LJ Marks, V Ritter, JE Agrusa, KY Kamdar, J Rivers, R Gardner, ... Blood Advances, 2025 | | 2025 |
| Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging Diagnosis J Cheng, Y Wang, S Gong, B Wistinghausen, S Jacobs, RJ Schore, ... Journal of Pediatric Hematology/Oncology 47 (1), e58-e61, 2025 | | 2025 |
| Early Leukapheresis in Patients with B-ALL Yields an Activated, Early Memory T-Cell Phenotype Associated with Response to CAR T-Cell Therapy A Dreyzin, Y Cai, KL Han, M Prochazkova, J Webb, K Toner, K Bushnell, ... Blood 144, 4853, 2024 | | 2024 |
| Pediatric T-lymphoblastic leukemia with an entirely mature immunophenotype: a prompt and challenging diagnosis J Cheng, Y Wang, B Wistinghausen, R Schore, K Toner, S Gong | | 2024 |
